Biomea Fusion (BMEA)
Develops oral small-molecule medicines for diabetes and obesity.
$1.92
Pre-market−0.02 (−0.78%)
At close$1.94(+7.50%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions68 holders · as of Mar 31, 2026 | 33.60% | 24.35M shares | |
| Insiders3 holders · as of Feb 6, 2026 | 2.78% | 2.02M shares | |
| Strategic holders2 holders · as of Feb 17, 2026 | 16.00% | 11.60M shares | |
| Otherremainder | 47.62% | 34.52M shares |
72.48M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
68 holders · 24.35M shares · 16 new positions · 32 increased · 13 reduced · 12 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 8.81M | 12.16% | 0 | May 15, 2026 |
| Vanguard Capital Management LLC | 2.60M | 3.58% | +2.60Mnew | May 15, 2026 |
| Aisling Capital Management LP | 2.05M | 2.83% | 0 | May 5, 2026 |
| Renaissance Technologies LLC | 1.31M | 1.81% | +834.2K | May 14, 2026 |
| Marshall Wace, LLP | 1.20M | 1.65% | +38.2K | May 15, 2026 |
| Citadel Advisors LLC | 656.8K | 0.91% | +656.8K | May 15, 2026 |
| Mariner, LLC | 654.6K | 0.90% | +68.9K | May 13, 2026 |
| BlackRock, Inc. | 641.4K | 0.88% | +9.4K | May 13, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| CVI Investments, Inc. | 9.90% | 7.85M | 13G | Feb 17, 2026 ↗ |
| Blue Owl Capital Holdings LP | 5.92% | 4.45M | 13G | Feb 12, 2026 ↗ |
| Janus Henderson Group PLC | 5.00% | 3.75M | 13G | Dec 8, 2025 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Dec 11, 2025 | Rainer M. Erdtmanndirector, officer: See Remarks | Purchase | 30,000 | $1.43 | 723,027 |
| Dec 2, 2025 | Michael J.M. Hitchcockdirector, officer: Interim CEO | Purchase | 100,000 | $0.9918 | 115,000 |
| Nov 28, 2025 | Rainer M. Erdtmanndirector, officer: See Remarks | Purchase | 40,000 | $1.10 | 683,027 |
| Dec 1, 2025 | Rainer M. Erdtmanndirector, officer: See Remarks | Purchase | 10,000 | $1.05 | 693,027 |
CongressHouse and Senate disclosures
Not reported.
